Novartis India Receives Detailed Public Statement for ₹552.49 Crore Open Offer

{
  "signal_id": "19af8208-923b-76fd-4901-c89921671ab1",
  "signal_type": "news",
  "signal_subtype": "sells_assets_to",
  "detected_at": "2026-09-13T06:53:30+00:00",
  "company": {
    "name": "Novartis",
    "domain": "novartis.com"
  },
  "data": {
    "url": "https://scanx.trade/stock-market-news/orders-deals/novartis-india-open-offer-waverise-investments-consortium-announces-552-49-crore-acquisition/33100840",
    "title": "Novartis India Receives Detailed Public Statement for ₹552.49 Crore Open Offer - scanx.trade",
    "assets": "equity share capital",
    "excerpt": "Novartis India Limited has received the detailed public statement from WaveRise Investments Limited and its consortium partners for their mandatory open offer to acquire 26% voting share capital at ₹860.64 per share. The comprehensive transaction includes underlying share purchase agreement for 70.68% stake acquisition from Novartis AG, with tendering period scheduled from April 21 to May 5, 2026. *this image is generated using AI for illustrative purposes only. Novartis India Limited has received the detailed public statement (DPS) dated February 25, 2026, from WaveRise Investments Limited and its consortium partners regarding their mandatory open offer. The company disclosed this development under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, confirming the formal progression of the acquisition proceedings. The acquiring consortium comprises WaveRise Investments Limited, ChrysCapital Fund X, and Two Infinity Partners, along with persons acting in concert ChrysCapital X, LLC and OceanEdge Investments Limited. The detailed public statement outlines the comprehensive framework for acquiring up to 64,19,608 equity shares from public shareholders. The offer price has been determined in accordance with Regulations 8(1) and 8(2) of SEBI (SAST) Regulations, considering the frequent trading status of Novartis India's equity shares on BSE...",
    "summary": "Novartis AG has agreed to sell its 70.68% stake in Novartis India Limited to a consortium led by WaveRise Investments Limited for a total consideration of ₹1,445.89 crore.",
    "planning": true,
    "image_url": "https://news-images.dhan.co/novartis-india-open-offer-waverise-investments-consortium-announces-552-49-crore-acquisition.jpg",
    "confidence": 0.9,
    "published_at": "2026-09-13T06:53:30Z",
    "effective_date": "2026-02-19",
    "article_sentence": "The open offer stems from a share purchase agreement dated February 19, 2026, between the consortium and Novartis AG."
  }
}

curl https://signals.autobound.ai/v1/signals/19af8208-923b-76fd-4901-c89921671ab1 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"novartis.com","limit":20}'